Actavis is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company has broad commercial reach extending across approximately 100 countries and is anchored by strong and sustainable brand franchises, a leading global generics business, a premier pipeline, highly efficient operations and an experienced management team. The Generics portfolio features more than 1,000 generics, branded generics, established brands and OTC products. The combined company is the third largest generic manufacturer in the U.S. and holds a top 5 leadership position in nearly 20 International markets. AFEC International have supported the Actavis with ongoing technical analysis and building infrastructure analysis. We have conducted on going peer reviews to ensure the buildings infrastructure is maintained at the highest level and ensuring that infrastructure alterations and improvements are carefully monitored and managed in line with all of the clients requirements.